ABRYSVO™ RSV vacc, preF A and preF B/PF 120 mcg / 0.5 mL Injection 0.5 mL

Features

• ABRYSVO™ is a vaccine indicated for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV)
• ABRYSVO is supplied in a kit that includes a vial of Lyophilized Antigen Component (NDC 0069-0207-01), a prefilled syringe containing Sterile Water Diluent Component (NDC 0069-0250-01) and a vial adapter
• The Lyophilized Antigen Component is reconstituted with the Sterile Water Diluent Component to form a single dose of ABRYSVO
• The vial stopper and the tip cap and rubber plunger of the prefilled syringe are not made with natural rubber latex
• Carton: 5 kits
• ABRYSVO is a vaccine indicated for: Active immunization of pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age
• ABRYSVO is a vaccine indicated for: Active immunization for the prevention of LRTD caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older